GONTERO, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 10124
EU - Europa 10067
AS - Asia 3237
SA - Sud America 71
AF - Africa 56
OC - Oceania 41
Continente sconosciuto - Info sul continente non disponibili 14
Totale 23610
Nazione #
US - Stati Uniti d'America 9984
IT - Italia 4054
CN - Cina 2007
IE - Irlanda 1320
SE - Svezia 1017
FR - Francia 888
KR - Corea 663
UA - Ucraina 504
DE - Germania 472
FI - Finlandia 455
AT - Austria 345
GB - Regno Unito 250
DK - Danimarca 210
VN - Vietnam 195
PL - Polonia 168
CA - Canada 116
IN - India 97
BE - Belgio 86
JP - Giappone 68
ES - Italia 63
TR - Turchia 47
NL - Olanda 43
HK - Hong Kong 39
CH - Svizzera 38
AU - Australia 36
BR - Brasile 28
RU - Federazione Russa 27
RO - Romania 26
SN - Senegal 24
PT - Portogallo 23
TW - Taiwan 21
IL - Israele 20
MX - Messico 20
UZ - Uzbekistan 20
GR - Grecia 14
IR - Iran 14
BY - Bielorussia 13
EU - Europa 13
CL - Cile 12
CO - Colombia 10
BO - Bolivia 9
SG - Singapore 9
MU - Mauritius 8
NO - Norvegia 8
AR - Argentina 7
TH - Thailandia 7
CZ - Repubblica Ceca 6
IQ - Iraq 6
BG - Bulgaria 5
HR - Croazia 5
NZ - Nuova Zelanda 5
SA - Arabia Saudita 5
GI - Gibilterra 4
ID - Indonesia 4
MY - Malesia 4
TN - Tunisia 4
ZA - Sudafrica 4
EC - Ecuador 3
KE - Kenya 3
MA - Marocco 3
MK - Macedonia 3
RS - Serbia 3
AE - Emirati Arabi Uniti 2
EE - Estonia 2
EG - Egitto 2
LT - Lituania 2
LU - Lussemburgo 2
LV - Lettonia 2
MZ - Mozambico 2
PE - Perù 2
PH - Filippine 2
PK - Pakistan 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
SM - San Marino 2
A1 - ???statistics.table.value.countryCode.A1??? 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BW - Botswana 1
CR - Costa Rica 1
CU - Cuba 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GT - Guatemala 1
HU - Ungheria 1
KW - Kuwait 1
LK - Sri Lanka 1
MC - Monaco 1
MD - Moldavia 1
NG - Nigeria 1
Totale 23610
Città #
Chandler 2309
Beijing 1363
Dublin 1305
Houston 888
Ann Arbor 729
Torino 612
Villeurbanne 529
Princeton 453
Medford 437
Wilmington 433
Fairfield 423
Nyköping 381
Jacksonville 376
Vienna 338
Dearborn 323
Woodbridge 218
Ashburn 196
Seattle 192
Cambridge 166
Milan 149
Rome 149
Boston 145
Warsaw 136
Redwood City 118
Dong Ket 117
Pisa 113
Hangzhou 97
Fremont 93
Norwalk 82
Guangzhou 71
Boardman 69
Brussels 62
Turin 56
Hebei 53
Mountain View 47
Toronto 45
Hefei 42
Munich 42
Verona 39
San Diego 37
Napoli 35
Falls Church 32
Seoul 32
Shanghai 28
Palermo 27
Chengdu 25
Nanjing 24
Genova 22
Kunming 22
Zhengzhou 22
Jinan 21
Ottawa 21
Naples 20
Central District 19
Chennai 19
Dallas 18
Padova 18
Taipei 18
Florence 17
Lachine 17
Paris 17
Phoenix 17
San Mateo 17
Xian 17
Bologna 16
Nanchang 16
Shenyang 16
Silver Spring 16
Chicago 15
Duncan 15
Wuhan 15
Bari 14
Berlin 14
Guiyang 14
New York 14
Wayne 14
Catania 13
Redmond 13
Tokyo 13
Changsha 12
Menlo Park 12
Istanbul 11
Polska 11
Trieste 11
Piemonte 10
Reggio Nell'emilia 10
São Paulo 10
Chongqing 9
Fuzhou 9
Missaglia 9
Nürnberg 9
Singapore 9
Sydney 9
Bolzano 8
Brindisi 8
Cagliari 8
Castelnuovo Rangone 8
Catanzaro 8
Amsterdam 7
Andover 7
Totale 14371
Nome #
Somministrazione intravescicale di Mitomicina C in ipertermia nei carcinomi vescicali superficiali a rischio intermedio 2970
Urological consequences following renal transplantation: a review of the literature 328
Efficacy and safety of a new device for intravesical thermochemotherapy in non-grade 3 BCG recurrent NMIBC: a phase I–II study 309
microRNA profiles in urine by next-generation sequencing can stratify bladder cancer subtypes 303
Intravesical thermo-chemotherapy based on conductive heat: a first pharmacokinetic study with Mitomycin C in superficial transitional cell carcinoma patients 287
Does Sex Reassignment Surgery Induce Cerebral Modifications in MTF Transsexuals? 271
MMP23B expression and protein levels in blood and urine are associated with bladder cancer 271
Older patients with low Charlson score and high-risk prostate cancer benefit from radical prostatectomy 245
External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection 237
Pharmacokinetic study to optimize the intravesical administration of gemcitabine 233
H2AX phosphorylation level in peripheral blood mononuclear cells as an event-free survival predictor for bladder cancer 230
A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or "chemopromotion"? 229
Urine microRNA profiling in bladder cancer by next-generation sequencing 217
New insights on occupational exposure and bladder cancer risk: a pooled analysis of two Italian case–control studies 204
The effects of glomerular and tubular renal progenitors and derived extracellular vesicles on recovery from acute kidney injury 203
Proteomic identification of Reticulocalbin 1 as potential tumor marker in renal cell carcinoma. 198
DKK-1 in prostate cancer diagnosis and follow up 179
Early diagnosis of bladder cancer through the detection of urinary tyrosine-phosphorylated proteins 171
Detection of multiple mutations in urinary exfoliated cells from male bladder cancer patients at diagnosis and during follow-up 166
Can DW-MRI, with its ADC values, be a reliable predictor of biopsy outcome in patients with suspected prostate cancer? 157
Circulating immunosuppressive cells of prostate cancer patients before and after radical prostatectomy: Profile comparison. 154
Targeting Taxanes to Castration-Resistant Prostate Cancer Cells by Nanobubbles and Extracorporeal Shock Waves 147
Pseudoprogression and hyperprogression during immune checkpoint inhibitor therapy for urothelial and kidney cancer 145
Sexual function after surgical treatment for penile cancer: Which organ-sparing approach gives the best results? 143
Role of HLA-G and extracellular vesicles in renal cancer stem cell-induced inhibition of dendritic cell differentiation 137
Pros-IT CNR: an Italian prostate cancer monitoring project 129
Prostatectomy restores the maturation competence of blood dendritic cell precursors and reverses the abnormal expansion of regulatory T lymphocytes. 128
A Pharmacokinetics Study to Optimize Intravesical Administration of Gemcitabine 127
Miliary pulmonary infection after BCG intravesical instillation: a rare, misdiagnosed and mistreated complication 125
Critical issues in current comparative and cost analyses between retropubic and robotic radical prostatectomy 123
Proposal of an improved prognostic classification for pT3 renal cell carcinoma 117
The prognostic value of basal DNA damage level in peripheral blood lymphocytes of patients affected by bladder cancer 116
Prostate Cancer Detection Rate with Koelis Fusion Biopsies versus Cognitive Biopsies: A Comparative Study 115
Increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of bladder cancer 114
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 103
Pretreatment tables predicting pathologic stage of locally advanced prostate cancer. 102
Surgical management of hypogonadic patients with hypotrophic testicles and small penis: A novel, combined technique with an infrapubic approach 102
Adrenal ganglioneuroma with multifocal retroperitoneal extension: a challenging diagnosis. 101
The Clinical Use of Statistical Permutation Test Methodology: A Tool for Identifying Predictive Variables of Outcome. 100
Impact of Lymph Node Burden on Survival of High-risk Prostate Cancer Patients Following Radical Prostatectomy and Pelvic Lymph Node Dissection 99
Self-Expandable Covered Metallic Stent (UVENTA) to Treat a Ureteral Stricture After Renal Transplant: A Case Report 99
Shortened telomere length and survival in bladder cancer patients 97
Tubulocystic renal cell carcinoma disguised as a renal cyst 89
Does kidney transplantation onto the external iliac artery affect the haemodynamic parameters of the cavernosal arteries? 88
Evaluation of P53 protein overexpression, Ki67 proliferative activity and mitotic index as markers of tumour recurrence in superficial transitional cell carcinoma of the bladder. 86
Prostate cancer detection with biparametric magnetic resonance imaging (bpMRI) by readers with different experience: performance and comparison with multiparametric (mpMRI) 86
A prospective multicentric international study on the surgical outcomes and patients' satisfaction rates of the 'sliding' technique for end-stage Peyronie's disease with severe shortening of the penis and erectile dysfunction 85
Comparsa in due fratelli di duplice neoplasia primitiva: carcinoma renale destro ed adenocarcinoma gastrico. 85
Shorter Leukocyte Telomere Length Is Independently Associated with Poor Survival in Patients with Bladder Cancer 85
A Comparative Study Between 2 Different Grafts Used as Patches After Plaque Incision and Inflatable Penile Prosthesis Implantation for End-Stage Peyronie's Disease 84
Detection of urinary prostate specific antigen by a lateral flow biosensor predicting repeat prostate biopsy outcome 84
A Single-center Analysis on the Learning Curve of Male-to-Female Penoscrotal Vaginoplasty by Multiple Surgical Measures 83
TREATMENT OF PROSTATE CANCER AND SEXUAL REHABILITATION WHEN A NERVE-SPARING PROCEDURE IS NOT FEASIBLE: PLACEMENT OF THE RESERVOIR FOR A THREE-COMPONENT PENILE IMPLANT DURING ROBOTIC EXTRA-APONEUROTIC RADICAL PROSTATECTOMY 83
SHORTENED TELOMERE LENGTH AND SURVIVAL IN BLADDER CANCER PATIENTS 81
A pilot phase-II prospective study to test the 'efficacy' and tolerability of a penile-extender device in the treatment of 'short penis' 80
A first pharmacokinetic study of mitomycin C intravesical thermo-chemotherapy for the treatment of superficial transitional cell carcinoma, "Beyond the Abstract," by Paola Milla, et al. 80
[Female incontinence surgery: state of the art] 80
SINGLE NUCLEOTIDE POLYMORPHISMS (SNP) AND HAPLOTYPES IN PSA PROMOTER: A NEW PROMISING PROSTATE CANCER SUSCEPTIBILITY AND PROGNOSIS PREDICTOR TOOL 79
A prospective randomized trial about music listening to decrease discomfort during SWL. 79
Costs in Surgical Techniques for Radical Prostatectomy: A Review of the Current State. 77
L’associazione tra tumore della vescica e esposizioni professionali: analisi pooled di due studi casocontrollo italiani. 77
Polymorphisms in the XRCC1 gene modify survival of bladder cancer patients treated with chemotherapy. 77
A pharmacokinetics study to optimize intravesical administration of gemcitabine 76
Galenic containing green tea polyphenols, lycopene and selenium: evaluation of chemopreventive activity in prostat cancer 76
An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer 76
Clinical efficacy of Apomorphine SL in erectile dysfunction of diabetic men. 75
An international field study of the EORTC QLQ-PR25: a Questionnaire for assessing the health-related quality of life of patients with prostate cancer 75
Effect of finasteride on the sensitivity of PSA to detect prostate cancer in rebiopsy series. 75
Treatment with plasmapheresis, immunoglobulins and rituximab for chronic-active antibody-mediated rejection in kidney transplantation: Clinical, immunological and pathological results 75
Extracellular vesicles from human liver stem cells inhibit renal cancer stem cell-derived tumor growth in vitro and in vivo 75
Penile fracture repair: assessment of early results and complications using color Doppler ultrasound. 74
Implant of ATOMS® system for the treatment of postoperative male stress urinary incontinence: results of a single centre 74
Re: A prospective study measuring penile length in men treated with radical prostatectomy for prostate cancer. M. Savoie, S. S. Kim and M. S. Soloway. J Urol, 169: 1462-1464, 2003. 72
Bladder tumor antigen assay as compared to voided urine cytology in the diagnosis of bladder cancer. 72
Advice on the counseling of patients seeking treatment for short penis. 70
Clinical judgment versus biomarker prostate cancer gene 3: which is best when determining the need for repeat prostate biopsy? 70
PHARMACOKINETICS, PHARMACOLOGICAL STABILITY, SAFETY AND ACTIVITY OF MMC ADMINISTERED WITH A NEW HYPERTHERMIA DEVICE (UNITHERMIA) 69
Polymorphisms in DNA repair genes, chemotherapy and survival in bladder cancer 69
Comment On: Applying Extender Devices in Patients with Penile Dysmorphophobia: Assessment of Tolerability, Efficacy, and Impact on Erectile Function 69
Chlamydia trachomatis versus common uropathogens as a cause of chronic bacterial prostatitis: Is there any difference? Results of a prospective parallel-cohort study 69
Small non-coding RNA profiling in plasma extracellular vesicles of bladder cancer patients by next-generation sequencing: Expression levels of miR-126-3p and piR-5936 increase with higher histologic grades 69
Adjustable Continence Therapy for the treatment of male stress urinary incontinence: a single-centre study. 68
Androgen deprivation modulates gene expression profile along prostate cancer progression 68
Recipient pre-existing chronic hypotension is associated with delayed graft function and inferior graft survival in kidney transplantation from elderly donors 68
Influence of previous pelvic radiation therapy in the outcome of radical cystectomy. 67
Treatment of multiple synchronous misdiagnosed renal cell cancers in a young patient affected by a "de novo" Von Hippel-Lindau syndrome 67
68Ga-PSMA-11 PET/CT in recurrent hormone-sensitive prostate cancer (HSPC): a prospective single-centre study in patients eligible for salvage therapy 66
Alfuzosin (10 mg) does not affect blood pressure in young healthy men 65
Renal artery aneurysm treated with laparoscopic nephrectomy, ex vivo repair and autotransplantation. 65
The strange case of a hematocele mistaken for a neoplastic scrotal mass 65
Is there an optimal time for intracavernous prostaglandin E1 rehabilitation following nonnerve sparing radical prostatectomy? Results from a hemodynamic prospective study. 65
Innovations in the endoscopic management of bladder cancer: is the era of white light cystoscopy over 64
Predicting survival in node-positive prostate cancer after open, laparoscopic or robotic radical prostatectomy: A competing risk analysis of a multi-institutional database 64
Proton pump inhibitors promote the growth of androgen-sensitive prostate cancer cells through ErbB2, ERK1/2, PI3K/Akt, GSK-3β signaling and inhibition of cellular prostatic acid phosphatase 64
Circadian antidiuretic hormone variation in elderly men complaining of persistent nocturia after urinary flow obstruction removal. 63
Actual experience and future development of gemcitabine in superficial bladder cancer 63
Adherence to Guidelines among Italian Urologists on Imaging Preoperative Staging of Low-Risk Prostate Cancer: Results from the MIRROR (Multicenter Italian Report on Radical Prostatectomy Outcomes and Research) Study 63
Retrograde Intrarenal Surgery is superior to SWL in the treatment of renal stones up to 20 mm 63
Cell-cycle Progression-Score Might Improve the Current Risk Assessment in Newly Diagnosed Prostate Cancer Patients 63
Pharmacokinetics, Pharmacological Stability, Safety and Efficacy of MMC Administered with a New Hyperthermia Device 63
Totale 14293
Categoria #
all - tutte 40930
article - articoli 0
book - libri 0
conference - conferenze 5943
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46873


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/20182262 0000 00 0417 1113430160142
2018/20192424 10577158106 284188 148290 146245420257
2019/20204142 254202263458 298808 403231 355291306273
2020/20213338 264256259194 352226 279182 324310263429
2021/20224148 131188185323 179136 198273 1272791154975
2022/20235319 760873157690 5941632 6076 0000
Totale 24703